Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $441.64 | 15 | 96.3% |
| Education | $16.89 | 1 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $119.08 | 1 | $0 (2022) |
| Ardelyx, Inc. | $89.62 | 3 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $46.21 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $41.15 | 2 | $0 (2024) |
| Amgen Inc. | $31.61 | 1 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $24.22 | 1 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $23.67 | 1 | $0 (2024) |
| Vifor Pharma, Inc. | $21.56 | 1 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $16.94 | 1 | $0 (2024) |
| Travere Therapeutics, Inc. | $16.89 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $315.23 | 14 | Ardelyx, Inc. ($89.62) |
| 2023 | $24.22 | 1 | Fresenius USA Marketing, Inc. ($24.22) |
| 2022 | $119.08 | 1 | AstraZeneca Pharmaceuticals LP ($119.08) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Nephrology | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/01/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: NEPHROLOGY | ||||||
| 06/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $33.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/27/2024 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $31.61 | General |
| Category: Nephrology | ||||||
| 03/11/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/22/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: CRITICAL CARE | ||||||
| 02/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Cardio-renal | ||||||
| 02/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: DIABETES | ||||||
| 02/01/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Hyperkalemia | ||||||
| 01/25/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 01/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $31.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/20/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $24.22 | General |
| 08/12/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $119.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 99 | 114 | $32,053 | $10,291 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $11,937 | $3,864 | 32.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 40 | $7,240 | $2,454 | 33.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $8,016 | $2,195 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 17 | $4,590 | $1,717 | 37.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 18 | 18 | $270.00 | $61.38 | 22.7% |
About Dr. Jack Rusing, MD
Dr. Jack Rusing, MD is a Nephrology healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2018. The National Provider Identifier (NPI) number assigned to this provider is 1720583206.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Rusing, MD has received a total of $458.53 in payments from pharmaceutical and medical device companies, with $315.23 received in 2024. These payments were reported across 16 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($441.64).
As a Medicare-enrolled provider, Rusing has provided services to 99 Medicare beneficiaries, totaling 114 services with total Medicare billing of $10,291. Data is available for 1 year (2023–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Denver, CO
- Active Since 03/27/2018
- Last Updated 01/09/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1720583206
Products in Payments
- LOKELMA (Drug) $119.08
- IBSRELA (Drug) $89.62
- LUPKYNIS (Drug) $46.21
- JARDIANCE (Drug) $41.15
- Parsabiv (Drug) $31.61
- TERLIVAZ (Drug) $23.67
- Veltassa (Drug) $21.56
- Kerendia (Drug) $16.94
- JYNARQUE (Drug) $14.14
- TARPEYO (Drug) $13.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Denver
Alexander Wiseman, Md, MD
Nephrology — Payments: $169,666
Dr. Brad Marder, Md, MD
Nephrology — Payments: $106,874
Dr. Laura Kooienga, Md, MD
Nephrology — Payments: $69,191
Maria-Gabriela Velez, Md, MD
Nephrology — Payments: $23,603
Jessica Kendrick, Md, MD
Nephrology — Payments: $23,473
Dr. Michael Shapiro, Md, MD
Nephrology — Payments: $7,269